It is noteworthy that the link between clinicopathological characteristics and the prognosis of breast cancer with the CYP1A2-rs17861162 SNP was first identified by Bai et al. They reported a significant correlation between the CYP1A2-rs17861162 SNP and factors such as age, menstrual status, and the presence of the P53 marker in women diagnosed with breast cancer. Here, TP53 is linked to breast cancer.